← 產業報告目錄
GMP Biologics Market, Share & Trends Analysis Report, By Type (Monoclonal Antibodies, Polyclonal Antibody), By Application (Hospitals, Clinics, Others), By Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-13頁數 165報告編號 INSIGHTACE-0f23478e97
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the GMP Biologics Market worldwide was assessed at USD 52.3 Bn. Analysts project it will progress to USD 153.9 Bn by 2031, at a CAGR of 14.6% spanning 2024 to 2031.
GMP Biologics covers The term "Good Manufacturing Practice" (GMP) Biologics describes the manufacture of biologic pharmaceuticals by strict legal requirements intended to guarantee the effectiveness, safety, and quality o. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GMP Biologics Market Snapshot
Chapter 4. Global GMP Biologics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Monoclonal Antibodies
5.2.2. Polyclonal Antibody
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Hospitals
6.2.2. Clinics
6.2.3. Others
Chapter 7. GMP Biologics Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.1.2. North America GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.1.3. North America GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.2.2. Europe GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.2.3. Europe GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.3.2. Asia Pacific GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.3.3. Asia Pacific GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Latin America GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.4.2. Latin America GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.4.3. Latin America GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.5.2. Middle East & Africa GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
7.5.3. Middle East & Africa GMP Biologics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Amgen Inc.
8.2.2. F. Hoffmann-La Roche Ltd
8.2.3. AbbVie Inc.
8.2.4. AstraZeneca plc
8.2.5. Merck KGaA
8.2.6. Creative Diagnostics
8.2.7. Fisher Bioservices (Thermo Fisher Scientific)
8.2.8. Polpharma Biologics
8.2.9. Intertek
8.2.10. HemaCare
8.2.11. AGC
8.2.12. AstraZeneca plc
8.2.13. Merck KGaA
8.2.14. Sanofi
8.2.15. GlaxoSmithKline plc
8.2.16. Johnson & Johnson
8.2.17. Pfizer Inc.
8.2.18. Novartis AG
8.2.19. Eli Lilly and Company
8.2.20. Samsung Biologics Co. Ltd.
8.2.21. WuXi AppTec
8.2.22. Lonza Group Ltd.
8.2.23. Rentschler Biopharma SE
8.2.24. Boehringer Ingelheim International GmbH
8.2.25. Celltrion Inc
8.2.26. Catalent Inc.
8.2.27. Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們